Brooks Laboratories partners with SteriScience

17 Sep 2020 Evaluate

Brooks Laboratories has entered into joint venture partnership with SteriScience. The global marketing joint-venture arrangement, shall focus on international markets such as USA, Europe and other regulated markets. Simultaneously the joint venture partners have also entered into manufacturing joint venture towards building a robust carbapenem business with integrated manufacturing capabilities, subject to approval from the shareholders of Brooks. This is a landmark value-accretive partnership, which furthers Brooks' global aspirations.

Brooks Laboratories has wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General dry powder Injectables, Ampoules and Liquid vials.

Brooks Laboratories Share Price

165.50 3.20 (1.97%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.